Since it was implemented on January 1, the USA's new Medicare prescription drug coverage has triggered many questions and concerns among health care providers and pharmacists. One of the most confusing aspects of the program is whether certain medicines should be billed under Medicare Part B or Part D.
In response, US firm Medical Learning has announced the addition of a "Medicare Part B versus Part D" table to MedLearnDrugCodes.com. Launched in 2005 under an exclusive agreement with R J Health Systems International, the web site offers hospitals and physicians a convenient, reliable source for up-to-date drug coding, pricing and reimbursement information, the company claims.
The new table guides subscribers through the process of determining which of the two benefits applies to a medication, based on criteria such as medical use of the drug, dosage form and whether it is provided in the context of another service. A frequently-asked-questions section helps further clarify coverage for various drug classes.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze